TY - JOUR
T1 - Dietary treatment of epilepsy
T2 - Rebirth of an ancient treatment
AU - Jóźwiak, Sergiusz
AU - Kossoff, Eric H.
AU - Kotulska-Jóźwiak, Katarzyna
N1 - Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2011
Y1 - 2011
N2 - Since its introduction in 1921, the ketogenic diet has been incontinuous use for children with difficult-to-control epilepsy.After decades of relative disuse, it is now both extremelypopular and well studied, with approximately two-thirds ofchildren demonstrating significant seizure reduction after 6 months. It is being used for less intractable seizures in childrenas well as recently adults. Modifications that helpimprove tolerability include the medium chain triglyceridediet, modified Atkins diet, and low glycemic index treatment.Major side effects include acidosis, increased cholesterol, kidneystones, gastroesophageal reflux, and growth disturbance.However, these side effects are usually treatable and nowadaysoften even preventable. Future non-epilepsy indicationssuch as Alzheimer disease, amyotrophic lateral sclerosis,autism, and brain tumors are under active investigation. Thisdietary treatment for epilepsy has undergone a rebirth. Itswidespread use in Poland and Europe is a welcome additionaltreatment for those with drug-resistant epilepsy.
AB - Since its introduction in 1921, the ketogenic diet has been incontinuous use for children with difficult-to-control epilepsy.After decades of relative disuse, it is now both extremelypopular and well studied, with approximately two-thirds ofchildren demonstrating significant seizure reduction after 6 months. It is being used for less intractable seizures in childrenas well as recently adults. Modifications that helpimprove tolerability include the medium chain triglyceridediet, modified Atkins diet, and low glycemic index treatment.Major side effects include acidosis, increased cholesterol, kidneystones, gastroesophageal reflux, and growth disturbance.However, these side effects are usually treatable and nowadaysoften even preventable. Future non-epilepsy indicationssuch as Alzheimer disease, amyotrophic lateral sclerosis,autism, and brain tumors are under active investigation. Thisdietary treatment for epilepsy has undergone a rebirth. Itswidespread use in Poland and Europe is a welcome additionaltreatment for those with drug-resistant epilepsy.
KW - Epilepsy
KW - Ketogenic diet
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=80054960763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80054960763&partnerID=8YFLogxK
U2 - 10.1016/S0028-3843(14)60108-0
DO - 10.1016/S0028-3843(14)60108-0
M3 - Review article
C2 - 22101998
AN - SCOPUS:80054960763
SN - 0028-3843
VL - 45
SP - 370
EP - 378
JO - Neurologia i Neurochirurgia Polska
JF - Neurologia i Neurochirurgia Polska
IS - 4
ER -